[CHRS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -143.29%
YoY- 35.68%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 45,352 45,424 60,151 60,115 73,371 82,503 87,643 -35.46%
PBT -58,870 -86,650 -50,150 -96,084 -45,725 -38,528 -29,900 56.89%
Tax 7,377 6,201 6,137 15,159 5,793 5,801 5,758 17.90%
NP -66,247 -92,851 -56,287 -111,243 -45,725 -38,528 -29,900 69.70%
Tax Rate - - - - - - - -
Total Cost 111,599 138,275 116,438 171,358 119,096 121,031 117,543 -3.39%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -146.07 -204.41 -93.58 -185.05 -62.32 -46.70 -34.12 162.95%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.85 -1.19 -0.73 -1.44 -0.60 -0.49 -0.40 65.06%
EPS Diluted -0.85 -1.19 -0.73 -1.44 -0.60 -0.49 -0.40 65.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.